Amgen, Biogen jump into copycat game amid string of biosimilars deals – FierceBiotech

With biosilimars coming whether developers of original biologics like it or not, major biotech outfits have changed their ... And the growth comes after a law last year called for the FDA to produce guidelines for developing biosimilars, which ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>